<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Bayer · Bull Run Post</title><link>https://bullrunpost.com/en/topic/bayer/</link><description>All the stories about Bayer from Bull Run Post, with context and rigour.</description><language>en</language><atom:link href="https://bullrunpost.com/en/topic/bayer/feed.xml" rel="self" type="application/rss+xml"/><item><title>Bayer lifts its 2026 EBITDA outlook, led by pharma and Nubeqa</title><link>https://bullrunpost.com/en/2026/11/03/bayer-raises-ebitda-guidance-nubeqa/</link><guid>https://bullrunpost.com/en/2026/11/03/bayer-raises-ebitda-guidance-nubeqa/</guid><pubDate>Tue, 03 Nov 2026 08:50:00 GMT</pubDate><description>The German group now expects 9.8 to 10.3 billion euros at constant currency, but it still reported a third-quarter net loss of 672 million.</description><category>Companies</category></item></channel></rss>
